Medincell

📍 Montpellier, France🗓 Founded 2002👥 178 employees💰 Last funded Sep 2025
Pharmaceutical Manufacturing🌐 medincell.com
Website LinkedIn
Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition for achieving our objectives. #BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
2002
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
3
United States
1
Investor activity2017–2025 · investors recorded per year
201712018220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Medincell?
Medincell has 4 investors on record on gritt.io.
When did Medincell last raise funding?
The most recent investment in Medincell recorded on gritt.io was in September 2025.
When was Medincell founded?
Medincell was founded in 2002.
What industry is Medincell in?
Medincell operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Medincell based?
Medincell is headquartered in Montpellier, France.